The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal

Ocular Immunology and Inflammation

Volumn 19, Issue 6, 2011, Pages 422-425

  Sitaula, Ranju ^a   Narayan Shah, Dev ^a   Singh, Divya ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

Author keywords

autoimmune; cataract; keratoconjunctivitis sicca; systemic lupus erythematous; vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; CHILD; DISEASE DURATION; DRUG INDUCED DISEASE; DRY EYE; EYE DISEASE; FEMALE; HERPES ZOSTER OPHTHALMICUS; HUMAN; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; NEPAL; OPTIC NERVE ATROPHY; OPTIC NEURITIS; RETINA MACULOPATHY; RETINOPATHY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIHYPERTENSIVE AGENTS; ANTIMALARIALS; CROSS-SECTIONAL STUDIES; EYE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; NEPAL; PREVALENCE; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81855196119     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.610023     Document Type: Article

References (30)

1. Foster CS. Ocular manifestations of systemic lupus erythematosus. Accessed January 2009. Available from www.uveitis. org/medical/articles/ clinical/ocularman.html.
2. Osio-Salidol E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus. 2010;19:1365-1373.
3. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol. 1972;56: 800-804.
4. Sivaraj R, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus (review). Rheumatology. 2007;46(12):1757-1762.
5. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271-1277.
6. Christie M Bartels. Systemic lupus erythematosus. Accessed February 2008. Available at emedicine.medscape.com article/332244-diagnosis.
7. Ushiyama O, Ushiyama K, Koarada S, et al. Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:705-708
8. Nguyen QD, Foster CS. Systemic lupus erythematosus and the eye. Int Ophthalmol Clin. 1998;38:33-60.
9. Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12(2): 87-99.
10. Farris RL. Sjogren's syndrome. In: Gold DH, Weingeist TA, eds. The Eye in Systemic Disease. Philadelphia: JB Lippincott;1990:70-71.
11. American Academy of Ophthalmology. Intraocular inflammation and uveitis, Basic and Clinical Science Course, Section 9: Chapter 7. American Academy of Ophthalmology; 2010- 2011: p.173.
12. Shern MA, Pirofsky B. Disseminated lupus erythematosus: analysis of thirty-four cases. Arth Intern Med. 1952; 90:790.
13. Stafford Brady JF, Urowitz MB, Gladman DD, et al. Lupus retinopathy: patterns, associations and prognosis. Arhthritis Rheum. 1988 Sep; 31(9): 1105-1110.
14. Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13:404-410.
15. Sahu DK. An unusual presentation of lupus retinopathy. Indian J Ophthalmol. 2008;56:72-73.
16. Chang P-C, Chen W-S, Lin H, et al. Combined central retinal artery and venous occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 2010;19:206-209.
17. Nguyen QD, Uy HS, Akpek EK, et al. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9: 288-298.
18. Sagduyu A, Çelebisoy N, Yünten N et al. Optic neuropathy and chiasmopathy as presenting manifestations of systemic lupus erythematosus. Neuro-Ophthalmology. 2004;28(4); 183-186.
19. Saleh Z, Menassa J, Abbas O, et al. Cranial nerve VI palsy as a rare initial presentation of systemic lupus erythematosus. Lupus. 2010;19:201-205.
20. Young CI, Kim SS, Kim HK. Bilateral optic neuritis as first manifestation of systemic lupus erythematosus. Ann Ophthalmol.1978;10:559-563.
21. Reddy CV, Foster CS. Systemic lupus erythematosus. In Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia:WB Saunders; 1994:2894-2901.
22. Montehermoso A, Cervera R, Font J. Association of Antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999;28:326-332.
23. Levine SR, Deegan MJ, Futrell N, et al. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies. Neurology.1990;40:1181- 1189.
24. Levine SR, Welch KM. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol. 1987;44:876-883.
25. Kleiner RC, Najarian LV, Schatten S, et al. Vasoocclusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology. 1989;96: 896-904.
26. Hughes JR, Davies JA. Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events. Thromb Res. 1998;89:101-106.
27. Golstein M, Meyer O, Bourgeois P. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol. 1993;11: 373-379.
28. Yap EY, Au Eong KG, Fong KY, et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus. Singapore Med J. 1998;39:557-559.
29. Al Saleh J., Jassim V. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008;17:62-66.
30. Soo MP, Chow SK, Tan CT, et al. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus. 2000;9: 511-514.